Cormorant Global Healthcare Master Fund, LP — SEC insider filings

SEC reporting owner CIK 1618442. 56 insider filings on record with FilingPulse; latest filed 2026-11-02.

Transaction summary — filings shown

Covers the 50 most recent of 56 filings on record, filed 2021-04-22 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Ambrx Biopharma Inc. (AMAM)10% owner411 legs · 10,965,823 sh · $114,106,979——
EyePoint, Inc. (EYPT)—624 legs · 4,794,057 sh · $89,496,4131 leg · 60,000 sh · $942,240—
MoonLake Immunotherapeutics (MLTX)—34 legs · 352,051 sh · $20,324,6405 legs · 6,499,978 sh · $46,868,184—
Corbus Pharmaceuticals Holdings, Inc. (CRBP)—631 legs · 1,932,632 sh · $53,693,2612 legs · 455,029 sh · $2,086,767—
Biomea Fusion, Inc. (BMEA)—72 legs · 1,300,000 sh · $27,300,000—6
Erasca, Inc. (ERAS)Director43 legs · 1,565,384 sh · $19,199,996—5
BRIGHT MINDS BIOSCIENCES INC. (DRUG)—211 legs · 422,591 sh · $3,234,3871 leg · 109,331 sh · $9,785,124—
Immuneering Corp (IMRX)10% owner31 leg · 550,000 sh · $8,250,00013 legs · 1,309,091 sh · $3,909,1842
Monte Rosa Therapeutics, Inc. (GLUE)10% owner11 leg · 600,000 sh · $11,400,000—3
Ventyx Biosciences, Inc. (VTYX)—11 leg · 625,000 sh · $10,000,000—3

+12 more issuers among the filings shown — every filing appears in the table below.

Insider filings — Cormorant Global Healthcare Master Fund, LP

FiledFormIssuerReported transactionsSource
2026-11-024Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Chen Bihua
Sale (S): 425,000 @ $4.10EDGAR
2026-08-104BlossomHill Therapeutics, Inc. (BLSM)
jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund V LP, Cormorant Private Healthcare Fund VI, LP
Conversion (C): 1,599,993 · Conversion (C): 1,701,541 · Purchase (P): 312,500 @ $16 · Grant/award (A): 23,904 (derivative) @ $0 · Conversion (C): 1,599,993 (derivative) · Conversion (C): 1,701,541 (derivative)EDGAR
2026-04-304BRIGHT MINDS BIOSCIENCES INC. (DRUG)
jointly with Cormorant Asset Management, LP, Chen Bihua
Sale (S): 109,331 @ $89.50EDGAR
2025-12-154Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Chen Bihua
Sale (S): 30,029 @ $11.46EDGAR
2025-12-084EyePoint, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Chen Bihua
Sale (S): 60,000 @ $15.70EDGAR
2025-10-014MoonLake Immunotherapeutics (MLTX)
jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP
Sale (S): 70,748 @ $9.38 · Sale (S): 232,460 @ $8.40 · Sale (S): 3,390,943 @ $7.58 · Sale (S): 2,800,000 @ $6.61 · Sale (S): 5,827 @ $6.96EDGAR
2025-08-014Biomea Fusion, Inc. (BMEA)
jointly with Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Holdings only — no transactions reportedEDGAR
2025-06-134Biomea Fusion, Inc. (BMEA)
jointly with Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Grant/award (A): 91,970 (derivative) @ $0EDGAR
2025-05-194OnKure Therapeutics, Inc. (OKUR)
jointly with Cormorant Asset Management, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Fund V LP, Chen Bihua
Sale (S): 1,813,439 @ $1.85EDGAR
2025-05-144OnKure Therapeutics, Inc. (OKUR)
jointly with Cormorant Asset Management, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP, Cormorant Private Healthcare Fund V LP, Chen Bihua
Sale (S): 24,300 @ $1.99EDGAR
2024-10-174BRIGHT MINDS BIOSCIENCES INC. (DRUG)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 238,097 @ $4.53 · Purchase (P): 63,173 @ $5.92 · Purchase (P): 33,343 @ $6.42 · Purchase (P): 8,900 @ $7.31 · Purchase (P): 2,600 @ $8.80 · Purchase (P): 2,700 @ $9.26 · +5 moreEDGAR
2024-09-244Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 45,085 @ $17.48 · Purchase (P): 25,943 @ $18.36 · Purchase (P): 66,088 @ $19.61 · Purchase (P): 139,551 @ $20.42 · Purchase (P): 47,564 @ $21.47 · Purchase (P): 25,769 @ $22.23EDGAR
2024-06-134Biomea Fusion, Inc. (BMEA)
jointly with Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Grant/award (A): 51,025 (derivative) @ $0EDGAR
2024-05-084EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 642,847 @ $11.70 · Purchase (P): 207,153 @ $12.36EDGAR
2024-04-224EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 395,244 @ $17.62 · Purchase (P): 186,521 @ $18.90EDGAR
2024-04-034Immuneering Corp (IMRX)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Sale (S): 100 @ $3.07 · Sale (S): 300 @ $3.06 · Sale (S): 100 @ $3.05 · Sale (S): 600 @ $3.03 · Sale (S): 10 @ $3.01 · Sale (S): 10 @ $2.98 · +2 moreEDGAR
2024-03-184Immuneering Corp (IMRX)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Sale (S): 345,266 @ $3.23 · Sale (S): 98,570 @ $4.25 · Sale (S): 54,215 @ $5.37 · Sale (S): 11,040 @ $5.97 · Sale (S): 400,000 @ $2.14EDGAR
2024-03-114Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 46,799 @ $37.82 · Purchase (P): 10,736 @ $39.13 · Purchase (P): 90,325 @ $39.99 · Purchase (P): 102,140 @ $41.23 · Purchase (P): 29,342 @ $41.23 · Purchase (P): 24,983 @ $42.25 · +4 moreEDGAR
2024-02-064Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 750,000 @ $19EDGAR
2024-01-304Corbus Pharmaceuticals Holdings, Inc. (CRBP)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 14,388 @ $25.73 · Purchase (P): 15,243 @ $26.66 · Purchase (P): 36,747 @ $27.70 · Purchase (P): 31,028 @ $28.82 · Purchase (P): 29,244 @ $29.42 · Purchase (P): 2,654 @ $31 · +8 moreEDGAR
2024-01-114EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 105,000 @ $21.32 · Purchase (P): 750,000 @ $19.75EDGAR
2023-12-124EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 588,235 @ $17EDGAR
2023-12-064EyePoint Pharmaceuticals, Inc. (EYPT)
jointly with Cormorant Asset Management, LP, Chen Bihua
Purchase (P): 321,259 @ $18.80 · Purchase (P): 945,664 @ $19.88 · Purchase (P): 122,625 @ $20.62 · Purchase (P): 79,805 @ $21.87 · Purchase (P): 28,090 @ $22.80 · Purchase (P): 37,081 @ $24.01 · +11 moreEDGAR
2023-10-254Ambrx Biopharma, Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Purchase (P): 1,307,311 @ $6.99EDGAR
2023-10-104MoonLake Immunotherapeutics (MLTX)
jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP
Purchase (P): 58,839 @ $59.90EDGAR
2023-10-044MoonLake Immunotherapeutics (MLTX)
jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund IV LP
Purchase (P): 74,911 @ $57.37 · Purchase (P): 150,487 @ $57.25 · Purchase (P): 67,814 @ $57.32EDGAR
2023-09-194Ambrx Biopharma Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Purchase (P): 1,401,505 @ $9.05 · Purchase (P): 751,233 @ $9.24EDGAR
2023-07-244GreenLight Biosciences Holdings, PBC (GRNA)
jointly with Cormorant Asset Management, LP, Cormorant Private Healthcare Fund II, LP, Chen Bihua
Sale (S): 9,188,659 @ $0EDGAR
2023-06-264Erasca, Inc. (ERAS)
jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Private Healthcare Fund II, LP
Grant/award (A): 60,000 (derivative) @ $0EDGAR
2023-06-164Biomea Fusion, Inc. (BMEA)
jointly with Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Grant/award (A): 6,989 (derivative) @ $0EDGAR
2023-04-204Ambrx Biopharma Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Purchase (P): 3,376,646 @ $11.27 · Purchase (P): 951,909 @ $11.15 · Purchase (P): 886,634 @ $11.60EDGAR
2023-04-174Ambrx Biopharma Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Purchase (P): 1,193,808 @ $9.16 · Purchase (P): 841,967 @ $9.96 · Purchase (P): 562,121 @ $10.67EDGAR
2023-04-034Biomea Fusion, Inc. (BMEA)
jointly with Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Purchase (P): 400,000 @ $30EDGAR
2023-03-164Ambrx Biopharma Inc. (AMAM)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Purchase (P): 250,000 @ $9.95 · Purchase (P): 250,000 @ $10.60 · Purchase (P): 500,000 @ $10.15EDGAR
2022-12-214/AErasca, Inc. (ERAS)
jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Private Healthcare Fund II, LP
Purchase (P): 307,692 @ $6.50EDGAR
2022-12-204Erasca, Inc. (ERAS)
jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Private Healthcare Fund II, LP
Purchase (P): 307,692 @ $6.50EDGAR
2022-06-244Biomea Fusion, Inc. (BMEA)
jointly with Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Grant/award (A): 23,867 (derivative) @ $0EDGAR
2022-01-134Vigil Neuroscience, Inc. (VIGL)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund IV LP
Conversion (C): 616,786 · Conversion (C): 616,786 (derivative)EDGAR
2021-10-274Ventyx Biosciences, Inc. (VTYX)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Conversion (C): 785,303 · Purchase (P): 625,000 @ $16 · Conversion (C): 548,288 (derivative) · Conversion (C): 237,015 (derivative)EDGAR
2021-10-154Pyxis Oncology, Inc. (PYXS)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Conversion (C): 668,854 · Purchase (P): 450,000 @ $16 · Conversion (C): 668,854 (derivative)EDGAR
2021-09-214Tyra Biosciences, Inc. (TYRA)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Conversion (C): 757,432 · Purchase (P): 312,500 @ $16 · Conversion (C): 757,432 (derivative)EDGAR
2021-08-054Immuneering Corp (IMRX)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Conversion (C): 1,702,628 · Purchase (P): 550,000 @ $15 · Conversion (C): 1,702,628 (derivative)EDGAR
2021-08-044Icosavax, Inc. (ICVX)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Conversion (C): 426,393 · Conversion (C): 426,393 (derivative)EDGAR
2021-07-224Erasca, Inc. (ERAS)
jointly with Chen Bihua, Cormorant Asset Management, LP, Cormorant Private Healthcare Fund II, LP
Conversion (C): 9,555,553 · Purchase (P): 950,000 @ $16 · Conversion (C): 4,000,000 (derivative) · Conversion (C): 4,166,666 (derivative) · Conversion (C): 1,388,887 (derivative)EDGAR
2021-07-074Aerovate Therapeutics, Inc. (AVTE)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund II, LP
Conversion (C): 1,530,691 · Purchase (P): 500,000 @ $14 · Conversion (C): 1,530,691 (derivative)EDGAR
2021-07-014Elevation Oncology, Inc. (ELEV)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Conversion (C): 1,983,168 · Purchase (P): 250,000 @ $16 · Conversion (C): 1,983,168 (derivative)EDGAR
2021-06-304Monte Rosa Therapeutics, Inc. (GLUE)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund II, LP
Conversion (C): 2,602,200 · Purchase (P): 600,000 @ $19 · Conversion (C): 2,124,343 (derivative) · Conversion (C): 477,857 (derivative)EDGAR
2021-06-234Verve Therapeutics, Inc. (VERV)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP
Conversion (C): 709,224 · Purchase (P): 275,000 @ $19 · Conversion (C): 709,224 (derivative)EDGAR
2021-04-294Rain Therapeutics Inc. (RAIN)
jointly with Cormorant Asset Management, LP, Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Private Healthcare Fund II, LP
Conversion (C): 2,326,657 · Purchase (P): 450,000 @ $17 · Conversion (C): 2,512,561 (derivative)EDGAR
2021-04-224Biomea Fusion, Inc. (BMEA)
jointly with Chen Bihua, Cormorant Private Healthcare Fund III LP, Cormorant Asset Management, LP
Conversion (C): 2,270,872 · Purchase (P): 900,000 @ $17 · Conversion (C): 2,270,872 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1618442 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs